Export

Erythropoiesis-stimulating agents
Essential medicine status
General description
Erythropoiesis-stimulating agents (ESAs) are biological proteins that stimulate the production of red blood cells. They are indicated for treatment of anaemia associated with chronic kidney disease.
INN
Epoetin alfa
Medicine type
Chemical agent
EML status history
First added in 2017 (TRS 1006) for Anaemia of chronic disease
Therapeutic equivalent for
Recommendations
Section
Antianaemia medicines
  • Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe